EVALUATION OF A BASAL BOLUS INSULIN PROTOCOL FOR CONTINUING DOSING EFFICACY AND SAFETY OPTIMIZATION

被引：0
|
作者：
Greene, Maureen [1 ]
机构：
[1] Wheaton Franciscan Healthcare St Joseph, Milwaukee, WI USA
来源：
CRITICAL CARE MEDICINE | 2014年 / 42卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
334
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Qualitative Evaluation of the Barriers and Facilitators Influencing the Use of an Electronic Basal Bolus Insulin Therapy Protocol to Improve the Care of Adult Inpatients With Diabetes
    Helmle, Karmon E.
    Edwards, Alun L.
    Kushniruk, Andre W.
    Borycki, Elizabeth M.
    CANADIAN JOURNAL OF DIABETES, 2018, 42 (05) : 459 - +
  • [32] REAL- WORLD EFFICACY AND SAFETY OF INSULIN DEGLUDEC, AN ULTRA-LONG ACTING BASAL INSULIN, IN BASAL-BOLUS TREATMENT WITH MEALTIME RAPID ACTING INSULIN IN TYPE 1 DIABETES IN INDIAN PEDIATRIC POPULATION
    Sethi, Aashish
    Kochar, Inderpal S.
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 612 - 613
  • [33] Glycemic Control After Basal-Bolus Insulin Protocol Initiation at a Veterans Affairs Medical Center
    Maturu, Amita V.
    Cizmic, Amber
    Manzi, Clarissa S.
    Mcaslan, Mary S.
    Schauer, Irene E.
    DIABETES, 2014, 63 : A623 - A623
  • [34] Changes in basal and bolus insulin pump dosing across gestation in women with well-controlled Type 1 diabetes
    Ramos, Gladys
    Roeder, Hilary
    Moore, Thomas
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2012, 206 (01) : S124 - S125
  • [35] USER ADHERENCE TO DOSING ADVICE OF AN ALGORITHM FOR BASAL BOLUS INSULIN THERAPY IN HOSPITALISED PATIENTS WITH DIABETES MELLITUS TYPE 2
    Mader, J. K.
    Neubauer, K.
    Schaupp, L.
    Augustin, T.
    Spat, S.
    Hoell, B.
    Beck, P.
    Pieber, T. R.
    Plank, J.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 : A14 - A15
  • [36] EFFICACY AND SAFETY OF BASAL BOLUS INSULIN REGIMEN IN A COHORT OF TYPE 2 DIABETES PATIENTS HOSPITALIZED IN GENERAL WARD ASSESSED BY CONTINUOUS GLUCOSE MONITORING
    Gomez, A. M.
    Henao Carrillo, D. C.
    Imitola Madero, A.
    Munoz, O. M.
    Rondon, M.
    Robledo, M. A.
    Rebolledo, M.
    Umpierrez, G.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A67 - A68
  • [37] Efficacy and safety of insulin degludec/liraglutide (IDegLira) vs basal-bolus therapy in patients with type 2 diabetes: DUAL VII trial
    Billings, L. K.
    Doshi, A.
    Gouet, D.
    Oviedo, A.
    Rodbard, H. W.
    Tentolouris, N.
    Gron, R.
    Halladin, N.
    Jodar, E.
    DIABETOLOGIA, 2017, 60 : S366 - S366
  • [38] THE DESIGN AND EVALUATION OF AN AUTOMATIC PRANDIAL INSULIN DOSING SYSTEM FOCUSED ON SAFETY
    Corbett, J.
    Lv, D.
    Breton, M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A17 - A18
  • [39] Efficacy and safety of insulin glulisine (GLU) versus insulin lispro (LIS) as part of a basal-bolus insulin regimen in children and adolescents with Type 1 diabetes (T1DM)
    Philotheou, A.
    Arslanian, S.
    Blatniczky, L.
    Peterkova, V.
    Souhami, E.
    Danne, T.
    DIABETIC MEDICINE, 2008, 25
  • [40] Comparable Efficacy and Safety of Insulin Glulisine and Insulin Lispro When Given as Part of a Basal-Bolus Insulin Regimen in a 26-Week Trial in Pediatric Patients with Type 1 Diabetes
    Philotheou, Areti
    Arslanian, Silva
    Blatniczky, Laszlo
    Peterkova, Valentina
    Souhami, Elisabeth
    Danne, Thomas
    DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (03) : 327 - 334
12345